CP-866,087 is a non-hormonal compound, acting on the central nervous system, which has been shown in animal models to restore sexual function.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
84
Tablets for oral administration
Tablets for oral administration
Tablets for oral administration
Pfizer Investigational Site
Dulwich, South Australia, Australia
Pfizer Investigational Site
Nedlands, Western Australia, Australia
Pfizer Investigational Site
Aarhus C, Denmark
Diary events, including Satisfactory Sexual Experiences (SSEs) over 6 weeks.
Time frame: 6 weeks
Score in Abbreviated Sexual Function Questionnaire after 6 weeks of treatment.
Time frame: 6 weeks
Exit interview at end of study. Meaningful Benefit Question at end of study.
Time frame: End of study
Measure of Female Sexual Distress questionnaire after 6 weeks of treatment.
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Tablets for oral administration
Pfizer Investigational Site
Kobenhavn OE, Denmark
Pfizer Investigational Site
Odense C, Denmark
Pfizer Investigational Site
Oslo, Norway
Pfizer Investigational Site
Westville, KwaZulu-Natal, South Africa
Pfizer Investigational Site
Pretoria, South Africa
Pfizer Investigational Site
Lund, Sweden
Pfizer Investigational Site
Skövde, Sweden
...and 2 more locations